Artwork

Content provided by OIS Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by OIS Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Revolutionizing Glaucoma Treatment and Innovation Insights

32:51
 
Share
 

Manage episode 386949392 series 2286865
Content provided by OIS Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by OIS Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

ViaLase, a clinical stage medical technology company located in Aliso Viejo, CA is focused on disrupting the conventional glaucoma treatment paradigm with the introduction of a truly noninvasive image-guided femtosecond laser treatment that enhances glaucoma patient care.

With a leadership team that has vast experience developing, designing, manufacturing, and commercializing the first femtosecond lasers for ophthalmic surgery for refractive and cataract patients, ViaLase is now bringing that expertise and innovation to glaucoma patients.

In this episode, Chief Commercialization Officer, Shawn O’Neil chats with OIS host Dr. Rob Rothman and discusses his successful product launches and instrumental contributions to ViaLase's commercialization strategy, their unique reimbursement strategy, the treatment's durability over time, enhancing its long-term impact, and much more.

Tune in and see how ViaLase plans to bring this revolutionary treatment to glaucoma patients across the globe.

Resources
ViaLase: https://www.vialase.com
Sean O’Neil: LinkedIn
Robert Rothman, MD ois.net/robert-rothman-md

  continue reading

402 episodes

Artwork
iconShare
 
Manage episode 386949392 series 2286865
Content provided by OIS Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by OIS Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

ViaLase, a clinical stage medical technology company located in Aliso Viejo, CA is focused on disrupting the conventional glaucoma treatment paradigm with the introduction of a truly noninvasive image-guided femtosecond laser treatment that enhances glaucoma patient care.

With a leadership team that has vast experience developing, designing, manufacturing, and commercializing the first femtosecond lasers for ophthalmic surgery for refractive and cataract patients, ViaLase is now bringing that expertise and innovation to glaucoma patients.

In this episode, Chief Commercialization Officer, Shawn O’Neil chats with OIS host Dr. Rob Rothman and discusses his successful product launches and instrumental contributions to ViaLase's commercialization strategy, their unique reimbursement strategy, the treatment's durability over time, enhancing its long-term impact, and much more.

Tune in and see how ViaLase plans to bring this revolutionary treatment to glaucoma patients across the globe.

Resources
ViaLase: https://www.vialase.com
Sean O’Neil: LinkedIn
Robert Rothman, MD ois.net/robert-rothman-md

  continue reading

402 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide